Table 3 Distribution of CYBA haplotypes between controls and patients of HLs and LLs
HLs, distribution (%) | Biostatistics | LLs, distribution (%) | Biostatistics | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Haplotypes | NHLs | HHLs | χ 2 | P-value | OR (95%CI) | NLLs | HLLs | χ 2 | P-value | OR (95%CI) |
rs8854A/ rs9932581G/rs4673C | 06 (1%) | 13 (3%) | 2.9 | 0.090 | 2.3 (0.9–6.2) | 162 (9%) | 139 (13%) | 13.5 | 0.0002 | 1.6 (1.3–2.1) |
rs8854G/ rs9932581A/rs4673C | 178 (36%) | 178 (37%) | 0.04 | 0.845 | 1.0 (0.8–1.3) | 354 (19%) | 193 (18%) | 0.5 | 0.472 | 0.9 (0.7–1.1) |
rs8854G/ rs9932581A/rs4673T | 76 (16%) | 43 (9%) | 10.3 | 0.001 | 0.5 (0.3–0.8) | 474 (25%) | 217 (20%) | 10.1 | 0.001 | 0.7 (0.6–0.9) |
rs8854G/ rs9932581G/rs4673C | 205 (42%) | 217 (45%) | 1.2 | 0.265 | 1.2 (0.9–1.5) | 549 (29%) | 380 (35%) | 7.5 | 0.006 | 1.3 (1.1–1.5) |
rs8854G/ rs9932581G/rs4673T | 23 (5%) | 31 (6%) | 1.0 | 0.313 | 1.3 (0.8–2.3) | 273 (15%) | 134 (12%) | 3.3 | 0.071 | 0.8 (0.6–1.0) |